High School DxD Season 3 was notably the final season produced under TNK, and more notably featured some material that was not from the original light novel releases. High School DxD Hero then finally ...
After a notable break between seasons, the High School DxD anime made its surprising return last year for a fourth outing. Not only was this new entry notable because it came out of the gate with a ...
New analysis of the DESTINY-Breast06 trial demonstrated that trastuzumab deruxtecan (T-DXd) provides meaningful clinical benefit regardless of time to progression on prior endocrine therapy, offering ...
Safety data further support datopotamab deruxtecan as a new treatment option in metastatic hormone receptor–positive, HER2-negative breast cancer. Patients with previously treated, inoperable or ...
The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results